“…In the structural modification of ageladine A, the general focus has thus far been placed on easy synthetical replacements of the C4-dibromopyrrole moiety with other heterocycles, [18,[24][25][26][27][28][29][30][31][32][33][34] and the substituent effects at the N1-position have not been evaluated except for as imple methyl group. [28,31] On the other hand, our new route to N1-substituted ageladine Ad erivatives is inspired by ar ather rare but naturally occurring PTM modification of arginineb yl ipid metabolites, discovered by Blair and coworkers in 2003 (Figure 2a). [35] Thus, the guanidine moiety of the arginineside chain in proteins can react under certain physiological conditions with the a,b-unsaturated aldehyde group of the lipid-oxidized metabolite 4-oxo-2(E)-nonenal( 4), efficientlyp roducing the C5-and N1-disubstituted 2-aminoimidazole 5,w hich mayb ecome the key intermediate of the N1-substituted ageladine A( see structure 11 in Figure 2b).…”